BenevolentAI is at the forefront of a revolution in drug discovery and development. We combine advanced AI and machine learning with cutting edge science to decipher complex disease biology and discover optimum therapeutic interventions.WHAT WE DO →
We have pioneered a fundamentally unique approach to AI-drug discovery. It begins with the belief that all biomedical information is valuable, so we analyse all relevant data sets from multiple and diverse modalities. Our computational R&D platform spans from data through to discovery and clinical development, enabling us to better understand the mysteries of human disease and increase the probability of discovering a successful drug.
Our Knowledge Graph incorporates the entire corpus of relevant, publicly available data and is continuously enriched by in-house experimental results. Our models extract and derive new insights which power our platform tools and build a clearer picture of disease.
We bring together deep technology and scientific expertise into a work culture that promotes continuous innovation and enables ideas to progress faster.
We expand AI across every step of the drug discovery process, encompassing target identification, small molecule drug discovery and patient stratification as we progress our portfolio of assets through clinical development.
We remove the bias and conventional boundaries and silos attributed to a specific pathway, disease, or therapeutic area, opening up a diverse disease space for exploration and experimentation.
Detailed mechanistic representations chart the interconnectivity of biology, enabling our scientists to investigate the aetiology of complex multifactorial diseases and find novel and optimal points of intervention.
We bring the most advanced technologies together with cutting edge science to decipher complex disease biology, de-risk drug development, and discover more effective therapies for patients in need. We believe we can build a healthier world in which no disease goes untreated. This is the future we are creating at BenevolentAI.
We work with the world’s leading pharmaceutical companies, biotechs and academic research institutions to unlock novel insights across every stage of the drug discovery process from Target Identification, Molecular Design, Precision Medicine and then through to Clinical Development.COllaborate →
We are an eclectic team of world-class scientists and technologists from diverse backgrounds united in a common purpose. We are passionate about building purposeful technology, and we are looking for exceptional people who share our vision and want to be part of our journey.